FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Parker

Research Profile

Disorders

Chemicals & Drugs

Physiology

Procedures

Anatomy

Concepts & Ideas

Co-author Network

Publications

TOP 3
Sean Jedrzkiewicz; John D Parker
Acute and chronic effects of glyceryl trinitrate therapy on insulin and glucose regulation in humans.
Mary Clare Luca; Kelsey McLaughlin; Tommaso Gori; Andrew Liuni; John D Parker
Daily ischemic preconditioning provides sustained protection from ischemia-reperfusion induced endothelial dysfunction: a human study.
William Chan; Rebecca Colman; John T Granton; Andrew D Michaels; John D Parker; Maryam Woldeyohannes; Patti Arand; Susanna Mak
Haemodynamic and structural correlates of the first and second heart sounds in pulmonary arterial hypertension: an acoustic cardiography cohort study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Parker (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sean Jedrzkiewicz; John D Parker
Acute and chronic effects of glyceryl trinitrate therapy on insulin and glucose regulation in humans.
Journal of cardiovascular pharmacology and therapeutics 2013;18(3):211-6.
2013: Mary Clare Luca; Kelsey McLaughlin; Tommaso Gori; Andrew Liuni; John D Parker
Daily ischemic preconditioning provides sustained protection from ischemia-reperfusion induced endothelial dysfunction: a human study.
Journal of the American Heart Association 2013;2(1):e000075.
2013: William Chan; Rebecca Colman; John T Granton; Andrew D Michaels; John D Parker; Maryam Woldeyohannes; Patti Arand; Susanna Mak
Haemodynamic and structural correlates of the first and second heart sounds in pulmonary arterial hypertension: an acoustic cardiography cohort study.
BMJ open 2013;3(4):.
2012: Kumar Perampaladas; Tommaso Gori; John D Parker
Rosiglitazone causes endothelial dysfunction in humans.
Journal of cardiovascular pharmacology and therapeutics 2012;17(3):260-5.
2012: Susanna Mak; Abdul Al-Hesayen; John J Granton; Klaus K Witte; John D Parker
Cardiac sympathetic activation in patients with pulmonary arterial hypertension.
American journal of physiology. Regulatory, integrative and comparative physiology 2012;302(10):R1153-7.
2012: Shahar Lavi; Andrew Liuni; Mary Clare Luca; Mark D Osten; Christopher B Overgaard; John D Parker; Kevin Thorpe; John Floras; Eric Horlick; Douglas Ing; Julie Lan; Warren J Cantor; Vladimír Džavík
Inhibition of sPLA2 and endothelial function: a substudy of the SPIDER-PCI trial.
The Canadian journal of cardiology 2012;28(2):215-21.
2011: Peter R Mitoff; Daniel Gam; Joan Ivanov; Abdul Al-Hesayen; Eduardo R Azevedo; Gary E Newton; John D Parker; Susanna Mak
Cardiac-specific sympathetic activation in men and women with and without heart failure.
Heart (British Cardiac Society) 2011;97(5):382-7.
2011: Dai Yumino; Hanqiao Wang; John S Floras; Gary E Newton; Susanna Mak; Pimon Ruttanaumpawan; John D Parker; T Douglas Bradley
Relation of periodic leg movements during sleep and mortality in patients with systolic heart failure.
The American journal of cardiology 2011;107(3):447-51.
2010: Steven E S Miner; Abdul Al-Hesayen; Lynne E Nield; Tommaso Gori; John D Parker
Acetylcholine acutely modifies nitric oxide synthase function in the human coronary circulation.
Experimental physiology 2010;95(12):1167-76.
2010: Amar Uxa; George R Thomas; Tommaso Gori; John D Parker
Standard versus low-dose transdermal nitroglycerin: differential effects on the development of tolerance and abnormalities of endothelial function.
Journal of cardiovascular pharmacology 2010;56(4):354-9.
2009: George R Thomas; Jonathan M DiFabio; Tommaso Gori; David J A Jenkins; John D Parker
Continuous therapy with transdermal nitroglycerin does not affect biomarkers of vascular inflammation and injury in healthy volunteers.
Canadian journal of physiology and pharmacology 2009;87(6):455-9.
2009: Dai Yumino; Hanqiao Wang; John S Floras; Gary E Newton; Susanna Mak; Pimon Ruttanaumpawan; John D Parker; T Douglas Bradley
Prevalence and physiological predictors of sleep apnea in patients with heart failure and systolic dysfunction.
Journal of cardiac failure 2009;15(4):279-85.
2009: Dai Yumino; H Wang; John S Floras; Gary E Newton; Susanna Mak; Pimon Ruttanaumpawan; John D Parker; T Douglas Bradley
Relationship between sleep apnoea and mortality in patients with ischaemic heart failure.
Heart (British Cardiac Society) 2009;95(10):819-24.
2008: Abdul Al-Hesayen; John D Parker
The effects of dobutamine on renal sympathetic activity in human heart failure.
Journal of cardiovascular pharmacology 2008;51(5):434-6.
2007: Hanqiao Wang; John D Parker; Gary E Newton; John S Floras; Susanna Mak; Kuo-Liang Chiu; Pimon Ruttanaumpawan; George Tomlinson; T Douglas Bradley
Influence of obstructive sleep apnea on mortality in patients with heart failure.
Journal of the American College of Cardiology 2007;49(15):1625-31.
2007: George R Thomas; Jonathan M DiFabio; Tommaso Gori; John D Parker
Once daily therapy with isosorbide-5-mononitrate causes endothelial dysfunction in humans: evidence of a free-radical-mediated mechanism.
Journal of the American College of Cardiology 2007;49(12):1289-95.
2007: J Malcolm O Arnold; Jonathan G Howlett; Paul Dorian; Anique Ducharme; Nadia Giannetti; Haissam Haddad; George A Heckman; Andrew Ignaszewski; Debra Isaac; Philip Jong; Peter Liu; Elizabeth Mann; Robert S McKelvie; Gordon W Moe; John D Parker; Anna M Svendsen; Ross T Tsuyuki; Kelly O'Halloran; Heather J Ross; Vivek Rao; Errol J Sequeira; Michel White
Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers.
The Canadian journal of cardiology 2007;23(1):21-45.
2006: Abdul Al-Hesayen; John S Floras; John D Parker
The effects of intravenous sildenafil on hemodynamics and cardiac sympathetic activity in chronic human heart failure.
European journal of heart failure 2006;8(8):864-8.
2006: Abdul Al-Hesayen; John D Parker
Adverse effects of atrioventricular synchronous right ventricular pacing on left ventricular sympathetic activity, efficiency, and hemodynamic status.
American journal of physiology. Heart and circulatory physiology 2006;291(5):H2377-9.
2006: Michael Arzt; Terry Young; Laurel Finn; James B Skatrud; Clodagh M Ryan; Gary E Newton; Susanna Mak; John D Parker; John S Floras; T Douglas Bradley
Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea.
Archives of internal medicine 2006;166(16):1716-22.
2006: Klaus K A Witte; John D Parker
Identification of lateral cardiac veins for cardiac resynchronization therapy.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2006;8(7):506-7.
2006: Jonathan M DiFabio; George R Thomas; Liana Zucco; Michael A Kuliszewski; Brian M Bennett; Michael J Kutryk; John D Parker
Nitroglycerin attenuates human endothelial progenitor cell differentiation, function, and survival.
The Journal of pharmacology and experimental therapeutics 2006;318(1):117-23.
2006: Klaus K A Witte; Rebecca R Pipes; Kumaraswamy Nanthakumar; John D Parker
Biventricular pacemaker upgrade in previously paced heart failure patients--improvements in ventricular dyssynchrony.
Journal of cardiac failure 2006;12(3):199-204.
2006: J Malcolm O Arnold; Peter Liu; Catherine Demers; Paul Dorian; Nadia Giannetti; Haissam Haddad; George A Heckman; Jonathan G Howlett; Andrew Ignaszewski; David E Johnstone; Philip Jong; Robert S McKelvie; Gordon W Moe; John D Parker; Vivek Rao; Heather J Ross; Errol J Sequeira; Anna M Svendsen; Koon Teo; Ross T Tsuyuki; Michel White
Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management.
The Canadian journal of cardiology 2006;22(1):23-45.
2006: Vijay S Chauhan; Eugene Downar; Kumaraswamy Nanthakumar; John D Parker; Heather J Ross; Wilson Chan; Peter Picton
Increased ventricular repolarization heterogeneity in patients with ventricular arrhythmia vulnerability and cardiomyopathy: a human in vivo study.
American journal of physiology. Heart and circulatory physiology 2006;290(1):H79-86.
2005: Toshihiko Kubo; John D Parker; Eduardo R Azevedo; Deborah J Atchison; Gary E Newton; Peter Picton; John S Floras
Vagal heart rate responses to chronic beta-blockade in human heart failure relate to cardiac norepinephrine spillover.
European journal of heart failure 2005;7(5):878-81.
2005: Peter J Cowburn; Harshna Patel; Rebecca R Pipes; John D Parker
Contrast nephropathy post cardiac resynchronization therapy: an under-recognized complication with important morbidity.
European journal of heart failure 2005;7(5):899-903.
2005: Klaus K A Witte; Sue J Kelly; John D Parker; Kumaraswamy Nanthakumar
Deployment of left ventricular lead from the ipsilateral side of central vein obstruction.
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 2005;13(1):47-50.
2005: Abdul Al-Hesayen; Eduardo R Azevedo; John S Floras; Shauna Hollingshead; Gary D Lopaschuk; John D Parker
Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization.
European journal of heart failure 2005;7(4):618-23.
2005: Peter J Cowburn; John D Parker; Douglas A Cameron; Louise Harris
Cardiac resynchronization therapy: retiming the failing right ventricle.
Journal of cardiovascular electrophysiology 2005;16(4):439-43.
2005: Peter J Cowburn; Harshna Patel; Robynn E Jolliffe; Robert W Wald; John D Parker
Cardiac resynchronization therapy: an option for inotrope-supported patients with end-stage heart failure?
European journal of heart failure 2005;7(2):215-7.
2005: Abdul Al-Hesayen; John D Parker
Renal handling of endothelin in patients with chronic heart failure.
The American journal of cardiology 2005;95(4):532-4.
2004: Tommaso Gori; Paula Harvey; John S Floras; John D Parker
Continuous therapy with nitroglycerin impairs endothelium-dependent vasodilation but does not cause tolerance in conductance arteries: a human in vivo study.
Journal of cardiovascular pharmacology 2004;44(5):601-6.
2004: Abdul Al-Hesayen; John D Parker
Impaired baroreceptor control of renal sympathetic activity in human chronic heart failure.
Circulation 2004;109(23):2862-5.
2004: S E S Miner; Abdul Al-Hesayen; S Kelly; T Benson; J J Thiessen; V R Young; John D Parker
L-arginine transport in the human coronary and peripheral circulation.
Circulation 2004;109(10):1278-83.
2004: John D Parker; Jake J Thiessen
Increased endothelin-1 production in patients with chronic heart failure.
American journal of physiology. Heart and circulatory physiology 2004;286(3):H1141-5.
2003: Tommaso Gori; Abdul Al-Hesayen; Courtney Jolliffe; John D Parker
Comparison of the effects of pentaerythritol tetranitrate and nitroglycerin on endothelium-dependent vasorelaxation in male volunteers.
The American journal of cardiology 2003;91(11):1392-4.
2003: Don D Sin; Fabia Fitzgerald; John D Parker; Gary E Newton; Alexander G Logan; John S Floras; T Douglas Bradley
Relationship of systolic BP to obstructive sleep apnea in patients with heart failure.
Chest 2003;123(5):1536-43.
2003: Michael E Detsky; Eduardo R Azevedo; John D Parker
Left ventricular isovolumic relaxation is a predictor of left ventricular end-diastolic pressure.
The Canadian journal of cardiology 2003;19(4):378-82.
2003: Tommaso Gori; Laura Saunders; Sofia Ahmed; John D Parker
Effect of folic acid on nitrate tolerance in healthy volunteers: differences between arterial and venous circulation.
Journal of cardiovascular pharmacology 2003;41(2):185-90.
2003: Richard S T Leung; Michael E Bowman; John D Parker; Gary E Newton; T Douglas Bradley
Avoidance of the left lateral decubitus position during sleep in patients with heart failure: relationship to cardiac size and function.
Journal of the American College of Cardiology 2003;41(2):227-30.
2002: Tommaso Gori; John S Floras; John D Parker
Effects of nitroglycerin treatment on baroreflex sensitivity and short-term heart rate variability in humans.
Journal of the American College of Cardiology 2002;40(11):2000-5.
2002: Tommaso Gori; John D Parker
Nitrate tolerance: a unifying hypothesis.
Circulation 2002;106(19):2510-3.
2002: Magdalena Ros; Eduardo R Azevedo; Gary E Newton; John D Parker
Effects of nitroprusside on cardiac norepinephrine spillover and isovolumic left ventricular relaxation in the normal and failing human left ventricle.
The Canadian journal of cardiology 2002;18(11):1211-6.
2002: Tommaso Gori; John D Parker
The puzzle of nitrate tolerance: pieces smaller than we thought?
Circulation 2002;106(18):2404-8.
2002: Catherine F Notarius; E R Azevedo; John D Parker; John S Floras
Peak oxygen uptake is not determined by cardiac noradrenaline spillover in heart failure.
European heart journal 2002;23(10):800-5.
2002: Abdul Al-Hesayen; Eduardo R Azevedo; Gary E Newton; John D Parker
The effects of dobutamine on cardiac sympathetic activity in patients with congestive heart failure.
Journal of the American College of Cardiology 2002;39(8):1269-74.
2002: John O Parker; John D Parker; Robert W Caldwell; Bernice Farrell; Wayne H Kaesemeyer
The effect of supplemental L-arginine on tolerance development during continuous transdermal nitroglycerin therapy.
Journal of the American College of Cardiology 2002;39(7):1199-203.
2001: Peter Liu; M Arnold; Israel Belenkie; Jonathan G Howlett; VF Huckell; A Ignazewski; Marie-Helene Leblanc; Robert S McKelvie; J Niznick; John D Parker; Vivek Rao; Heather Ross; Denis Roy; S Smith; Bruce Sussex; Koon Teo; Ross T Tsuyuki; Michel White; D Beanlands; Victoria Bernstein; R Davies; D Issac; David E Johnstone; H Lee; Gordon W Moe; G Newton; Peter Pflugfelder; S Roth; Jean Rouleau; Salim Yusuf
The 2001 Canadian Cardiovascular Society consensus guideline update for the management and prevention of heart failure.
The Canadian journal of cardiology 2001;17 Suppl E():5E-25E.
2001: Toshihiko Kubo; Eduardo R Azevedo; Gary E Newton; John D Parker; John S Floras
Lack of evidence for peripheral alpha(1)- adrenoceptor blockade during long-term treatment of heart failure with carvedilol.
Journal of the American College of Cardiology 2001;38(5):1463-9.
2001: Eduardo R Azevedo; T Kubo; Susanna Mak; Abdul Al-Hesayen; A Schofield; R Allan; S Kelly; Gary E Newton; John S Floras; John D Parker
Nonselective versus selective beta-adrenergic receptor blockade in congestive heart failure: differential effects on sympathetic activity.
Circulation 2001;104(18):2194-9.
2001: Tommaso Gori; S S Mak; S Kelly; John D Parker
Evidence supporting abnormalities in nitric oxide synthase function induced by nitroglycerin in humans.
Journal of the American College of Cardiology 2001;38(4):1096-101.
2001: Tommaso Gori; J M Burstein; S Ahmed; S E Miner; Abdul Al-Hesayen; S Kelly; John D Parker
Folic acid prevents nitroglycerin-induced nitric oxide synthase dysfunction and nitrate tolerance: a human in vivo study.
Circulation 2001;104(10):1119-23.
2001: U Jurt; Tommaso Gori; Amir Ravandi; Saeid Babaei; P Zeman; John D Parker
Differential effects of pentaerythritol tetranitrate and nitroglycerin on the development of tolerance and evidence of lipid peroxidation: a human in vivo study.
Journal of the American College of Cardiology 2001;38(3):854-9.
2001: Eduardo R Azevedo; A M Schofield; S Kelly; John D Parker
Nitroglycerin withdrawal increases endothelium-dependent vasomotor response to acetylcholine.
Journal of the American College of Cardiology 2001;37(2):505-9.
2000: D D Martin; J S Tong; John D Parker
Platelet cyclic GMP responses to nitroglycerin.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2000;14(4):419-25.
2000: Eduardo R Azevedo; Gary E Newton; John S Floras; John D Parker
Reducing cardiac filling pressure lowers norepinephrine spillover in patients with chronic heart failure.
Circulation 2000;101(17):2053-9.
2000: Eduardo R Azevedo; Gary E Newton; AB Parker; John S Floras; John D Parker
Sympathetic responses to atrial natriuretic peptide in patients with congestive heart failure.
Journal of cardiovascular pharmacology 2000;35(1):129-35.
1999: Paulo Caramori; Valter C Lima; P H Seidelin; Gary E Newton; John D Parker; AG Adelman
Long-term endothelial dysfunction after coronary artery stenting.
Journal of the American College of Cardiology 1999;34(6):1675-9.
1999: SD Milone; Eduardo R Azevedo; C Forster; John D Parker
The angiotensin II-receptor antagonist losartan does not prevent hemodynamic or vascular tolerance to nitroglycerin.
Journal of cardiovascular pharmacology 1999;34(5):645-50.
1999: Don D Sin; Fabia Fitzgerald; John D Parker; G Newton; John S Floras; T Douglas Bradley
Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure.
American journal of respiratory and critical care medicine 1999;160(4):1101-6.
1999: E R Azevedo; John D Parker
Parasympathetic control of cardiac sympathetic activity: normal ventricular function versus congestive heart failure.
Circulation 1999;100(3):274-9.
1999: Gary E Newton; Eduardo R Azevedo; John D Parker
Inotropic and sympathetic responses to the intracoronary infusion of a beta2-receptor agonist: a human in vivo study.
Circulation 1999;99(18):2402-7.
1999: SD Milone; Cecil R Pace-Asciak; Denis Reynaud; Eduardo R Azevedo; Gary E Newton; John D Parker
Biochemical, hemodynamic, and vascular evidence concerning the free radical hypothesis of nitrate tolerance.
Journal of cardiovascular pharmacology 1999;33(5):685-90.
1999: John D Parker; Jake J Thiessen; R Reilly; J H Tong; D J Stewart; A S Pandey
Human endothelin-1 clearance kinetics revealed by a radiotracer technique.
The Journal of pharmacology and experimental therapeutics 1999;289(1):261-5.
1999: A G Fried; AB Parker; Gary E Newton; John D Parker
Electrical and hemodynamic correlates of the maximal rate of pressure increase in the human left ventricle.
Journal of cardiac failure 1999;5(1):8-16.
1999: SD Milone; Gary E Newton; John D Parker
Hemodynamic and biochemical effects of 100% oxygen breathing in humans.
Canadian journal of physiology and pharmacology 1999;77(2):124-30.
1999: Eduardo R Azevedo; Gary E Newton; John D Parker
Cardiac and systemic sympathetic activity in response to clonidine in human heart failure.
Journal of the American College of Cardiology 1999;33(1):186-91.
1998: Paulo Caramori; AG Adelman; Eduardo R Azevedo; Gary E Newton; AB Parker; John D Parker
Therapy with nitroglycerin increases coronary vasoconstriction in response to acetylcholine.
Journal of the American College of Cardiology 1998;32(7):1969-74.
1998: John D Parker
Clinical outcome studies of anti-anginal drug therapy for patients with stable coronary disease: an indication for clinical trials.
European heart journal 1998;19 Suppl I():I15-9.
1998: John D Parker
Diuretic therapy and angina pectoris.
Cardiologia (Rome, Italy) 1998;43(3):261-5.
1998: John D Parker; J O Parker
Nitrate therapy for stable angina pectoris.
The New England journal of medicine 1998;338(8):520-31.
1997: Gary E Newton; AG Adelman; Valter C Lima; P H Seidelin; E Schampaert; John D Parker
Cardiac sympathetic activity in response to acute myocardial ischemia.
The American journal of physiology 1997;272(5 Pt 2):H2079-84.
1997: John D Parker; AB Parker; B Farrell; John O Parker
The effect of hydralazine on the development of tolerance to continuous nitroglycerin.
The Journal of pharmacology and experimental therapeutics 1997;280(2):866-75.
1996: Gary E Newton; John D Parker
Cardiac sympathetic responses to acute vasodilation. Normal ventricular function versus congestive heart failure.
Circulation 1996;94(12):3161-7.
1996: Gary E Newton; AB Parker; J S Landzberg; W S Colucci; John D Parker
Muscarinic receptor modulation of basal and beta-adrenergic stimulated function of the failing human left ventricle.
The Journal of clinical investigation 1996;98(12):2756-63.
1996: John D Parker
Counterregulatory responses: sustained-release isosorbide-5-mononitrate versus transdermal nitroglycerin.
Journal of cardiovascular pharmacology 1996;28(5):631-8.
1996: Gary E Newton; John D Parker
Acute effects of beta 1-selective and nonselective beta-adrenergic receptor blockade on cardiac sympathetic activity in congestive heart failure.
Circulation 1996;94(3):353-8.
1996: Gary E Newton; J H Tong; A M Schofield; A D Baines; John S Floras; John D Parker
Digoxin reduces cardiac sympathetic activity in severe congestive heart failure.
Journal of the American College of Cardiology 1996;28(1):155-61.
1996: John D Parker
Potential problems with intermittent nitrate therapy.
The Canadian journal of cardiology 1996;12 Suppl C():22C-24C.
1996: John D Parker; AB Parker; B Farrell; J O Parker
Effects of diuretic therapy on the development of tolerance to nitroglycerin and exercise capacity in patients with chronic stable angina.
Circulation 1996;93(4):691-6.
1995: John D Parker; Gary E Newton; J S Landzberg; John S Floras; W S Colucci
Functional significance of presynaptic alpha-adrenergic receptors in failing and nonfailing human left ventricle.
Circulation 1995;92(7):1793-800.
1995: John D Parker; AB Parker; B Farrell; J O Parker
Intermittent transdermal nitroglycerin therapy. Decreased anginal threshold during the nitrate-free interval.
Circulation 1995;91(4):973-8.
1994: S C Jacobs; R Friedman; John D Parker; Geoffrey H Tofler; A H Jimenez; James E Muller; H Benson; Peter H Stone
Use of skin conductance changes during mental stress testing as an index of autonomic arousal in cardiovascular research.
American heart journal 1994;128(6 Pt 1):1170-7.
1994: John D Parker; M A Testa; A H Jimenez; Geoffrey H Tofler; James E Muller; J O Parker; Peter H Stone
Morning increase in ambulatory ischemia in patients with stable coronary artery disease. Importance of physical activity and increased cardiac demand.
Circulation 1994;89(2):604-14.
1994: J S Landzberg; John D Parker; D F Gauthier; Wilson S Colucci
Effects of intracoronary acetylcholine and atropine on basal and dobutamine-stimulated left ventricular contractility.
Circulation 1994;89(1):164-8.
1993: John D Parker; J O Parker
Effect of therapy with an angiotensin-converting enzyme inhibitor on hemodynamic and counterregulatory responses during continuous therapy with nitroglycerin.
Journal of the American College of Cardiology 1993;21(6):1445-53.
1992: J O Parker; John D Parker
Neurohormonal activation during nitrate therapy: a possible mechanism for tolerance.
The American journal of cardiology 1992;70(8):93B-97B.
1992: John D Parker; B Farrell; T Fenton; J O Parker
Effects of diuretic therapy on the development of tolerance during continuous therapy with nitroglycerin.
Journal of the American College of Cardiology 1992;20(3):616-22.
1992: John A Bittl; Alan C Yeung; V Vekshtein; John D Parker; R D Fish
Estimation of mitral valve area from regression analysis of the pressure gradient in mitral stenosis.
The American journal of cardiology 1992;69(12):1050-5.
1992: M D Tischler; Richard T Lee; Theodore Plappert; G H Mudge; Martin St John Sutton; John D Parker
Serial assessment of left ventricular function and mass after orthotopic heart transplantation: a 4-year longitudinal study.
Journal of the American College of Cardiology 1992;19(1):60-6.
1991: John D Parker; B Farrell; T Fenton; M Cohanim; J O Parker
Counter-regulatory responses to continuous and intermittent therapy with nitroglycerin.
Circulation 1991;84(6):2336-45.
1991: M D Tischler; Martin St John Sutton; John A Bittl; John D Parker
Effects of percutaneous mitral valvuloplasty on left ventricular mass and volume.
The American journal of cardiology 1991;68(9):940-4.
1991: J S Landzberg; John D Parker; D F Gauthier; Wilson S Colucci
Effects of myocardial alpha 1-adrenergic receptor stimulation and blockade on contractility in humans.
Circulation 1991;84(4):1608-14.
1991: John D Parker; J S Landzberg; John A Bittl; I Mirsky; Wilson S Colucci
Effects of beta-adrenergic stimulation with dobutamine on isovolumic relaxation in the normal and failing human left ventricle.
Circulation 1991;84(3):1040-8.
1990: Peter H Stone; R S Gibson; Stephen P Glasser; M A DeWood; John D Parker; D T Kawanishi; M H Crawford; F C Messineo; T L Shook; K Raby
Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group.
Circulation 1990;82(6):1962-72.
1989: W S Colucci; John D Parker
Effects of beta-adrenergic agents on systolic and diastolic myocardial function in patients with and without heart failure.
Journal of cardiovascular pharmacology 1989;14 Suppl 5():S28-37.